Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

Online
ISSN
1437-4331
See all formats and pricing
Volume 49, Issue 3 (Mar 2011)

Issues

S100B protein in neurodegenerative disorders

Johann Steiner
  • Department of Psychiatry, University of Magdeburg, Magdeburg, Germany
  • Pembroke College, University of Cambridge, Cambridge, UK
  • Email:
/ Bernhard Bogerts
  • Department of Psychiatry, University of Magdeburg, Magdeburg, Germany
/ Matthias L. Schroeter
  • Max-Planck-Institute for Human Cognitive and Brain Sciences, Leipzig, Germany
  • Day Clinic of Cognitive Neurology, University of Leipzig, Leipzig, Germany
/ Hans-Gert Bernstein
  • Department of Psychiatry, University of Magdeburg, Magdeburg, Germany
Published Online: 2011-02-09 | DOI: https://doi.org/10.1515/CCLM.2011.083

Abstract

“Classic” neurodegenerative disorders, such as Alzheimer's disease and amyotrophic lateral sclerosis share common pathophysiological features and involve progressive loss of specific neuronal populations, axonal or synaptic loss and dysfunction, reactive astrogliosis, and reduction in myelin. Furthermore, despite the absence of astrogliosis, impaired expression of astrocyte- and oligodendrocyte-related genes has been observed in patients with major psychiatric disorders, including schizophrenia and mood disorders. Because S100B is expressed in astrocytes and oligodendrocytes, its concentration in cerebrospinal fluid (CSF) or serum has been considered a suitable surrogate marker for the diagnostic or prognostic assessment of neurodegeneration. This review summarizes previous postmortem, CSF and serum studies regarding the role of S100B in this context. A general drawback is that only small single-center studies have been performed. Many potential confounding factors exist because of the wide extra-astrocytic and extracerebral expression of S100B. Due to lack of disease specificity, reliance on S100B concentrations for differential diagnostic purposes in cases of suspected neurodegenerative disorders is not recommended. Moreover, there is no consistent evidence for a correlation between disease severity and concentrations of S100B in CSF or serum. Therefore, S100B has limited usefulness for monitoring disease progression.

Keywords: S100; S100B; Alzheimer's disease; amyotro-phic lateral sclerosis; dementia; Parkinson's disease; schizophrenia

About the article

Corresponding author: Johann Steiner, MD, Department of Psychiatry, University of Magdeburg, Leipziger Str. 44, 39120 Magdeburg, Germany Phone: +49-391-6715019, Fax: +49-391-6715223


Received: 2010-07-03

Accepted: 2010-12-14

Published Online: 2011-02-09

Published in Print: 2011-03-01


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2011.083. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Daniela F. de Souza, Krista M. Wartchow, Paula S. Lunardi, Giovana Brolese, Lucas S. Tortorelli, Cristiane Batassini, Regina Biasibetti, and Carlos-Alberto Gonçalves
Frontiers in Cellular Neuroscience, 2015, Volume 9
[2]
Wendy E. Heywood, Daniela Galimberti, Emily Bliss, Ernestas Sirka, Ross W. Paterson, Nadia K. Magdalinou, Miryam Carecchio, Emma Reid, Amanda Heslegrave, Chiara Fenoglio, Elio Scarpini, Jonathan M. Schott, Nick C. Fox, John Hardy, Kailash Bahtia, Simon Heales, Neil J. Sebire, Henrik Zetterburg, and Kevin Mills
Molecular Neurodegeneration, 2015, Volume 10, Number 1
[3]
C. Hernández-García, A. Rodríguez-Rodríguez, and J.J. Egea-Guerrero
Brain Injury, 2015, Page 1
[5]
Fernanda Hansen, Cíntia Eickhoff Battú, Márcio Ferreira Dutra, Fabiana Galland, Franciane Lirio, Núbia Broetto, Patrícia Nardin, and Carlos-Alberto Gonçalves
Amino Acids, 2015
[6]
Hui Liu, Yu Zhang, Yan-Bo Ren, Jian Kang, Jing Xing, Qing-Hui Qi, Dong-Na Gao, Tao Ma, Xiao-Wei Liu, and Zhi Liu
International Immunopharmacology, 2015, Volume 27, Number 1, Page 69
[7]
Berna Cagatay Kaya, Hasan Karadag, Ozgur Oner, Aysegul Kart, and Mehmet Hakan Turkcapar
Psychiatry Investigation, 2015, Volume 12, Number 2, Page 260
[8]
Shuai Wang, Huixun Ren, Jie Xu, Yanjun Yu, Shuiping Han, Hui Qiao, Shaoli Cheng, Chang Xu, Shucheng An, Bomiao Ju, Chengyuan Yu, Chanyuan Wang, Tao Wang, Zhenjun Yang, Ethan Will Taylor, and Lijun Zhao
Scientific Reports, 2015, Volume 5, Page 7977
[9]
Christian Benedict, Liisa Byberg, Jonathan Cedernaes, Pleunie S. Hogenkamp, Vilmantas Giedratis, Lena Kilander, Lars Lind, Lars Lannfelt, and Helgi B. Schiöth
Alzheimer's & Dementia, 2014
[10]
Maria da Graça Cantarelli, Ana Carolina Tramontina, Marina C. Leite, and Carlos-Alberto Gonçalves
Psychiatry Research, 2014, Volume 220, Number 3, Page 745
[11]
Björn Bluhm, Björn Laffer, Daniela Hirnet, Matthias Rothermundt, Oliver Ambree, and Christian Lohr
The Cerebellum, 2015, Volume 14, Number 2, Page 119
[12]
C Scuderi, C Stecca, M Valenza, P Ratano, M R Bronzuoli, S Bartoli, L Steardo, E Pompili, L Fumagalli, P Campolongo, and L Steardo
Cell Death and Disease, 2014, Volume 5, Number 9, Page e1419
[13]
P. Spitzer, Z. Kohl, P. Golitz, R. Coras, I. Blumcke, W. Bruck, A. Dorfler, and C. Maihofner
Case Reports, 2014, Volume 2014, Number jun02 1, Page bcr2012008510
[14]
Kara E. O'Connell, Jogin Thakore, and Kumlesh K. Dev
Schizophrenia Research, 2014, Volume 156, Number 1, Page 1
[15]
Paul C Guest, Man K Chan, Michael G Gottschalk, and Sabine Bahn
Biomarkers in Medicine, 2014, Volume 8, Number 1, Page 15
[16]
Annya M, Smyth, Stephen M, and Lawrie
Clinical Psychopharmacology and Neuroscience, 2013, Volume 11, Number 3, Page 107
[17]
Marina Cretich, Laura Sola, Paola Gagni, and Marcella Chiari
Expert Review of Molecular Diagnostics, 2013, Volume 13, Number 8, Page 863
[18]
Filipe Marques Gonçalves, Andiara Espíndola Freitas, Tanara Vieira Peres, Débora Kurrle Rieger, Juliana Ben, Mariana Maestri, Ana Paula Costa, Ana Carolina Tramontina, Carlos Alberto Gonçalves, Ana Lúcia Severo Rodrigues, Celso Shiniti Nagano, Edson Holanda Teixeira, Kyria S. Nascimento, Benildo Sousa Cavada, and Rodrigo Bainy Leal
Neurochemical Research, 2013, Volume 38, Number 11, Page 2375
[19]
Souhel Najjar, Daniel Pearlman, Orrin Devinsky, Amanda Najjar, Siddhartha Nadkarni, Tracy Butler, and David Zagzag
Cognitive And Behavioral Neurology, 2013, Volume 26, Number 1, Page 36
[20]
Silvia Yelmo-Cruz, Armando L. Morera-Fumero, and Pedro Abreu-González
Psychiatry and Clinical Neurosciences, 2013, Volume 67, Number 2, Page 67
[21]
Amanda M. Titler, Jessica M. Posimo, and Rehana K. Leak
Cell and Tissue Research, 2013, Volume 352, Number 3, Page 427
[22]
Claudio Peri, Paola Gagni, Fabio Combi, Alessandro Gori, Marcella Chiari, Renato Longhi, Marina Cretich, and Giorgio Colombo
ACS Chemical Biology, 2013, Volume 8, Number 2, Page 397
[23]
Kira G Hartman, Laura E McKnight, Melissa A Liriano, and David J Weber
Future Medicinal Chemistry, 2013, Volume 5, Number 1, Page 97
[24]
Ana Rodríguez-Rodríguez, Juan José Egea-Guerrero, Antonio León-Justel, Elena Gordillo-Escobar, Jaume Revuelto-Rey, Ángel Vilches-Arenas, Antonio Carrillo-Vico, José María Domínguez-Roldán, Francisco Murillo-Cabezas, and Juan Miguel Guerrero
Clinica Chimica Acta, 2012, Volume 414, Page 228
[25]
Jwa-Kyung Kim, Sung Gyun Kim, Hyung Jik Kim, and Young Rim Song
Clinical Biochemistry, 2012, Volume 45, Number 18, Page 1573
[26]
Ozgur Yalcinbayir, Rifat Levent Buyukuysal, Berna Akova-Budak, and Oner Gelisken
Current Eye Research, 2012, Volume 37, Number 11, Page 1030
[27]
Fabrizio Michetti, Valentina Corvino, Maria Concetta Geloso, Wanda Lattanzi, Camilla Bernardini, Laura Serpero, and Diego Gazzolo
Journal of Neurochemistry, 2012, Volume 120, Number 5, Page 644
[28]
Vikas Kaura and Stephen Bonner
Trends in Anaesthesia and Critical Care, 2012, Volume 2, Number 1, Page 42
[29]
Ana Paula Costa, Ana Carolina Tramontina, Regina Biasibetti, Cristiane Batassini, Mark William Lopes, Krista Minéia Wartchow, Caren Bernardi, Lucas Silva Tortorelli, Rodrigo Bainy Leal, and Carlos- Alberto Gonçalves
Behavioural Brain Research, 2012, Volume 226, Number 2, Page 420
[30]
G. A. Ushakova, O. Z. Fomenko, and S. G. Pierzynowski
Neurophysiology, 2011, Volume 43, Number 3, Page 205
[31]
Johann Steiner, Nicole Marquardt, Inga Pauls, Kolja Schiltz, Hassan Rahmoune, Sabine Bahn, Bernhard Bogerts, Reinhold E. Schmidt, and Roland Jacobs
Brain, Behavior, and Immunity, 2011, Volume 25, Number 6, Page 1233

Comments (0)

Please log in or register to comment.
Log in